바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.75 No.4
Citation Share

A Case of Mycobacterium kansasii Pulmonary Disease Presenting as Endobronchial Lesions in HIV-Infected Patient

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2013, v.75 no.4, pp.157-160









& (2013). A Case of Mycobacterium kansasii Pulmonary Disease Presenting as Endobronchial Lesions in HIV-Infected Patient. Tuberculosis & Respiratory Diseases, 75(4), 157-160.
  • Downloaded
  • Viewed
PDF Download

Abstract

Incidence of nontuberculous mycobacterium (NTM) pulmonary disease is increasing with the wider recognition and development of diagnostic technology. Mycobacterium kansasii is the second most common pathogen of NTM pulmonary disease in human immunodeficiency virus (HIV)-infected patients. However in Korea, the incidence of M. kansasii pulmonary disease is relatively low, and there has been no report of M. kansasii pulmonary disease with bronchial involvement in HIV patients, to the best of our knowledge. We report a case of M. kansasii pulmonary disease presenting with endobronchial lesions in an HIV-infected patient complaining of chronic cough with bilateral enlargements of hilar lymph nodes on chest X-ray.

keywords
Mycobacterium kansasii, Bronchial Diseases, HIV

Reference

1.

Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.

2.

Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006;129:341-8.

3.

Griffith DE. Management of disease due to Mycobacterium kansasii. Clin Chest Med 2002;23:613-21.

4.

Park SY, Park JH, Jegal YJ, Lee JH, Lim CM, Lee SD, et al. A case of idiopathic CD4+ T-lymphocytopenia with disseminated Mycobacterium kansasii infection and pulmonary alveolar proteinosis. Tuberc Respir Dis 2000;48:377-82.

5.

Koh WJ, Kwon OJ, Suh GY, Chung MP, Kim H, Lee NY, et al. A case report of three patients with nontuberculous mycobacterial pulmonary disease caused by Mycobacterium kansasii. Tuberc Respir Dis 2003;54:459-66.

6.

Maliwan N, Zvetina JR. Clinical features and follow up of 302 patients with Mycobacterium kansasii pulmonary infection: a 50 year experience. Postgrad Med J 2005;81:530-3.

7.

Connolly MG Jr, Baughman RP, Dohn MN. Mycobacterium kansasii presenting as an endobronchial lesion. Am Rev Respir Dis 1993;148:1405-7.

8.

Manali ED, Tomford WJ, Liao DW, Farver C, Mehta AC. Mycobacterium kansasii endobronchial ulcer in a nonimmunocompromised patient. Respiration 2005;72:305-8.

9.

An JY, Lee JE, Park HW, Lee JH, Yang SA, Jung SS, et al. Clinical and bronchoscopic features in endobronchial tuberculosis. Tuberc Respir Dis 2006;60:532-9.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy